Anti-CD3 Therapy Promotes Tolerance by Selectively Depleting Pathogenic Cells while Preserving Regulatory T Cells-Reference-Cited by-同舟云学术

Anti-CD3 Therapy Promotes Tolerance by Selectively Depleting Pathogenic Cells while Preserving Regulatory T Cells

Published:2011-07-08 Issue:4 Volume:187 Page:2015-2022
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Penaranda Cristina,Tang Qizhi,Bluestone Jeffrey A.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference37 articles.

1. CD3-specific antibodies: a portal to the treatment of autoimmunity

2. Immunologic monitoring with monoclonal antibodies to human T-cell subsets.;Cosimi;Transplant. Proc.,1981

3. RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN-2, AND GAMMA-INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTS

4. Systemic Reaction to the Anti–T-Cell Monoclonal Antibody OKT3 in Relation to Serum Levels of Tumor Necrosis Factor and Interferon-α

5. An anti-murine CD3 monoclonal antibody with a low affinity for Fcγ receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity.;Alegre;J. Immunol.,1995

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immunology of type 1 diabetes;Nature Reviews Immunology;2024-02-02

2. In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism;Small;2023-12-10

3. A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab;Diabetologia;2023-10-02

4. Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes;Advanced Materials;2023-08-16

5. Efficacy of anti‐CD3 monoclonal antibodies in delaying the progression of recent‐onset type 1 diabetes mellitus: A systematic review, meta‐analyses and meta‐regression;Diabetes, Obesity and Metabolism;2023-08-14